Efficacy of oral beta-agonist maintenance therapy in preterm labor

A meta-analysis

George A. Macones, Michelle Berlin, Jesse A. Berlin

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Objective: To analyze the available data on the efficacy of oral beta-agonist maintenance therapy in delaying delivery and in decreasing the incidence of preterm birth and its complications. Data Sources: A computer search of English-language abstracts using MEDLINE (medical subject heading terms: labor, premature and beta-adrenergic receptor agonist, therapeutic use) was supplemented with a review of the bibliographies of obstetric texts to identify randomized trials of oral beta-agonist maintenance therapy. Methods of Study Selection: Six trials were identified, of which four met our inclusion criteria for the meta-analysis. Data Extraction and Synthesis: Trials to be included in this meta-analysis underwent trial quality evaluation and data abstraction independently by two blinded investigators. An estimate of the odds ratio (OR) and risk difference was calculated for the dichotomous outcomes using both a random effects model and a fixed effects model. Continuous outcomes were pooled using a simple weighted average of the within-study difference in means. The pooled OR for preventing preterm delivery was 1.09 (95% confidence interval [CI] 0.60-1.99) and the OR for preventing recurrent preterm labor was 1.05 (95% CI 0.53-2.05). The pooled difference in the mean interval to delivery was -0.22 days (95% CI -2.5 to +1.99). Conclusions: The available data do not support a role for beta-agonist maintenance therapy after resolution of an acute episode of preterm labor in reducing the incidence of preterm delivery, increasing the interval to delivery, or reducing the incidence of recurrent preterm labor.

Original languageEnglish (US)
Pages (from-to)313-317
Number of pages5
JournalObstetrics and Gynecology
Volume85
Issue number2
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Premature Obstetric Labor
Meta-Analysis
Odds Ratio
Confidence Intervals
Incidence
Medical Subject Headings
Adrenergic beta-Agonists
Information Storage and Retrieval
Premature Birth
Bibliography
Therapeutic Uses
Therapeutics
MEDLINE
Obstetrics
Language
Research Personnel

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Efficacy of oral beta-agonist maintenance therapy in preterm labor : A meta-analysis. / Macones, George A.; Berlin, Michelle; Berlin, Jesse A.

In: Obstetrics and Gynecology, Vol. 85, No. 2, 1995, p. 313-317.

Research output: Contribution to journalArticle

@article{459fe9a8b17e42078ea245a209dada81,
title = "Efficacy of oral beta-agonist maintenance therapy in preterm labor: A meta-analysis",
abstract = "Objective: To analyze the available data on the efficacy of oral beta-agonist maintenance therapy in delaying delivery and in decreasing the incidence of preterm birth and its complications. Data Sources: A computer search of English-language abstracts using MEDLINE (medical subject heading terms: labor, premature and beta-adrenergic receptor agonist, therapeutic use) was supplemented with a review of the bibliographies of obstetric texts to identify randomized trials of oral beta-agonist maintenance therapy. Methods of Study Selection: Six trials were identified, of which four met our inclusion criteria for the meta-analysis. Data Extraction and Synthesis: Trials to be included in this meta-analysis underwent trial quality evaluation and data abstraction independently by two blinded investigators. An estimate of the odds ratio (OR) and risk difference was calculated for the dichotomous outcomes using both a random effects model and a fixed effects model. Continuous outcomes were pooled using a simple weighted average of the within-study difference in means. The pooled OR for preventing preterm delivery was 1.09 (95{\%} confidence interval [CI] 0.60-1.99) and the OR for preventing recurrent preterm labor was 1.05 (95{\%} CI 0.53-2.05). The pooled difference in the mean interval to delivery was -0.22 days (95{\%} CI -2.5 to +1.99). Conclusions: The available data do not support a role for beta-agonist maintenance therapy after resolution of an acute episode of preterm labor in reducing the incidence of preterm delivery, increasing the interval to delivery, or reducing the incidence of recurrent preterm labor.",
author = "Macones, {George A.} and Michelle Berlin and Berlin, {Jesse A.}",
year = "1995",
doi = "10.1016/0029-7844(94)00374-M",
language = "English (US)",
volume = "85",
pages = "313--317",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Efficacy of oral beta-agonist maintenance therapy in preterm labor

T2 - A meta-analysis

AU - Macones, George A.

AU - Berlin, Michelle

AU - Berlin, Jesse A.

PY - 1995

Y1 - 1995

N2 - Objective: To analyze the available data on the efficacy of oral beta-agonist maintenance therapy in delaying delivery and in decreasing the incidence of preterm birth and its complications. Data Sources: A computer search of English-language abstracts using MEDLINE (medical subject heading terms: labor, premature and beta-adrenergic receptor agonist, therapeutic use) was supplemented with a review of the bibliographies of obstetric texts to identify randomized trials of oral beta-agonist maintenance therapy. Methods of Study Selection: Six trials were identified, of which four met our inclusion criteria for the meta-analysis. Data Extraction and Synthesis: Trials to be included in this meta-analysis underwent trial quality evaluation and data abstraction independently by two blinded investigators. An estimate of the odds ratio (OR) and risk difference was calculated for the dichotomous outcomes using both a random effects model and a fixed effects model. Continuous outcomes were pooled using a simple weighted average of the within-study difference in means. The pooled OR for preventing preterm delivery was 1.09 (95% confidence interval [CI] 0.60-1.99) and the OR for preventing recurrent preterm labor was 1.05 (95% CI 0.53-2.05). The pooled difference in the mean interval to delivery was -0.22 days (95% CI -2.5 to +1.99). Conclusions: The available data do not support a role for beta-agonist maintenance therapy after resolution of an acute episode of preterm labor in reducing the incidence of preterm delivery, increasing the interval to delivery, or reducing the incidence of recurrent preterm labor.

AB - Objective: To analyze the available data on the efficacy of oral beta-agonist maintenance therapy in delaying delivery and in decreasing the incidence of preterm birth and its complications. Data Sources: A computer search of English-language abstracts using MEDLINE (medical subject heading terms: labor, premature and beta-adrenergic receptor agonist, therapeutic use) was supplemented with a review of the bibliographies of obstetric texts to identify randomized trials of oral beta-agonist maintenance therapy. Methods of Study Selection: Six trials were identified, of which four met our inclusion criteria for the meta-analysis. Data Extraction and Synthesis: Trials to be included in this meta-analysis underwent trial quality evaluation and data abstraction independently by two blinded investigators. An estimate of the odds ratio (OR) and risk difference was calculated for the dichotomous outcomes using both a random effects model and a fixed effects model. Continuous outcomes were pooled using a simple weighted average of the within-study difference in means. The pooled OR for preventing preterm delivery was 1.09 (95% confidence interval [CI] 0.60-1.99) and the OR for preventing recurrent preterm labor was 1.05 (95% CI 0.53-2.05). The pooled difference in the mean interval to delivery was -0.22 days (95% CI -2.5 to +1.99). Conclusions: The available data do not support a role for beta-agonist maintenance therapy after resolution of an acute episode of preterm labor in reducing the incidence of preterm delivery, increasing the interval to delivery, or reducing the incidence of recurrent preterm labor.

UR - http://www.scopus.com/inward/record.url?scp=0028821624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028821624&partnerID=8YFLogxK

U2 - 10.1016/0029-7844(94)00374-M

DO - 10.1016/0029-7844(94)00374-M

M3 - Article

VL - 85

SP - 313

EP - 317

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 2

ER -